Sector Watch: Healthcare - Sep 27 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $121.87 +1.26 1.04% | XBI: $95.99 -0.13 -0.14% | Updated Sep 27, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| CSBR52WH Champions Oncology $186.7M |
16.72+2.51 1.0 M 4.0x |
18% | ||
| ARAY Accuray $397.9M |
4.60+0.60 5.7 M 9.5x |
15% | ||
| LPTX Leap Therapeutics $118.2M |
8.04+1.03 235.9 K 4.5x |
15% | ||
| AGTC52WH Applied Genetic Technologies $133.3M |
7.35+0.85 645.2 K 3.5x |
13% | ||
| EYPT52WH Eyepoint Pharmaceuticals $280.2M |
3.76+0.41 1.9 M 4.2x |
12% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| GERN52WL Geron $424.2M |
2.31-3.92 82.7 M 8.9x |
-63% | ||
| CCXI ChemoCentryx $544.6M |
10.81-2.38 1.2 M 6.2x |
-18% | ||
| OPK Opko Health Inc $1.8B |
3.29-0.43 5.5 M |
-12% | ||
| ANGO AngioDynamics $800.8M |
21.60-2.63 957.3 K 5.8x |
-11% | ||
| NTRA Natera $1.3B |
22.14-2.64 1.1 M |
-11% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, USAT and MCHP [globenewswire.com]AngioDynamics Reports Fiscal 2019 First Quarter Financial Results | Business Wire [businesswire.com]
Microscopic Polyangiitis (MPA) Pipeline Review, H2 2018 - Therapeutic Assessment of 5 Companies - ResearchAndMarkets.com | Business Wire [businesswire.com]
Geron to Provide an Update on the Imetelstat Collaboration with Janssen on September 27, 2018 [globenewswire.com]
AGTC to Present at Upcoming Conferences Nasdaq:AGTC [globenewswire.com]
Janssen Elects Not to Continue Agreement with Geron for Imetelstat [prnewswire.com]
Geron Corp. (GERN) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws [prnewswire.com]
The 10th Annual 'Silicon Valley Reinvents the Wheel' Automotive Technology Conference returns to Mountain View's Computer History Museum on Monday, October 1 [prnewswire.com]
ChemoCentryx Announces Proposed Public Offering of Common Stock [globenewswire.com]
ChemoCentryx to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference [globenewswire.com]
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against OPKO Health, Microchip Technology, and Cocrystal and Encourages Investors to Contact the Firm [globenewswire.com]
Kessler Topaz Meltzer & Check, LLP ? Important Deadline Reminder for OPKO Health, Inc. Investors [globenewswire.com]
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In OPKO Health, Inc. To Contact The Firm | Business Wire [businesswire.com]
Largest Prostate SBRT Studies to Date Show Accuray CyberKnife® System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions [prnewswire.com]
Leap Therapeutics to Present at Two October Conferences [prnewswire.com]
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | Business Wire [businesswire.com]
Proliferative Diabetic Retinopathy (PDR) Review, H2 2018: Pipeline Analysis of 7 Companies & Drug Profiles - ResearchAndMarkets.com | Business Wire [businesswire.com]
Global Uveitis Pipeline Review, H2 2018 - 32 Companies & Drug Pipelines - ResearchAndMarkets.com | Business Wire [businesswire.com]
AGTC Appoints William Aliski to its Board of Directors Nasdaq:AGTC [globenewswire.com]
CLASS ACTION UPDATE for USAT and OPK: Levi & Korsinsky, LLP Notifies Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
Pomerantz Law Firm Announces the Filing of a Class Action against OPKO Health, Inc. and Certain Officers ? OPK [globenewswire.com]
Glomerulonephritis - Pipeline Review, H2 2018 - Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type - ResearchAndMarkets.com | Business Wire [businesswire.com]
OPK LOSS NOTICE ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against OPKO Health, Inc.; Important Deadline - OPK [prnewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PVG OPK and USAT [globenewswire.com]
OPKO November 13th Deadline: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. - OPK [globenewswire.com]
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In OPKO Health, Inc. To Contact The Firm [globenewswire.com]
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed against OPKO Health, Inc. | Business Wire [businesswire.com]
AngioDynamics to Present at the Cantor Global Healthcare Conference | Business Wire [businesswire.com]
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fanhua, Pretium Resources, and OPKO Health and Encourages Investors to Contact the Firm [globenewswire.com]
AngioDynamics to Present at the Cantor Global Healthcare Conference | Business & Finance | manchestertimes.com [businesswire.com]
CLASS ACTION UPDATE for CBS PVG OPK USAT and TRCO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
VIFOR PHARMA GROUP INCREASES EQUITY INVESTMENT IN CHEMOCENTRYX [globenewswire.com]
Scott+Scott Attorneys at Law LLP Alerts Investors to the Filing of Securities Class Action Against OPKO Health, Inc. (OPK) [prnewswire.com]
Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased OPKO Health, Inc. Common Stock [prnewswire.com]
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In OPKO Health, Inc. To Contact The Firm [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
